This article discusses ethical responsibility and legal liability issues regarding use of IBM Watson TM for clinical decision making. In a case, a patient presents with symptoms of leukemia. Benefits and limitations of using Watson or other intelligent clinical decision-making tools are considered, along with precautions that should be taken before consulting artificially intelligent systems. Guidance for health care professionals and organizations using artificially intelligent tools to diagnose and to develop treatment recommendations are also offered.
No takes yet. Share an insight, caveat, or question.
David D. Luxton (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: